NCT04029714View on ClinicalTrials.gov

Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment

NAActive, not recruitingINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions
Prostate Cancer
Interventions
PROCEDURE

Active Surveillance

Active monitoring of prostate cancer and curative treatment if there are signs of tumor progression.

Trial Locations (5)

Unknown

Bedford Hospital, Bedford

Epsom & St. Helier, London

Guy's Hospital, London

Queen Elizabeth Hospital, London

Royal Mardsen Hospital, London

All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

Uppsala University

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT04029714 - Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment | Biotech Hunter | Biotech Hunter